Immunogenicity 14901
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
ZNF263
Transcript ID
uc010uww.2
HLA INFO
A*24:02
TCR INFO
No TCR info found!
Full length protein sequence (331 aa)
MEQAL
1
AGASS
6
GRELG
11
RPKEL
16
QPKKL
21
HLCPL
26
CGKNF
31
SNNSN
36
LIRHQ
41
RIHAA
46
ERLCM
51
GVDCT
56
EIFGG
61
NPRFL
66
SLHRA
71
HLGEE
76
AHKCL
81
ECGKC
86
FSQNT
91
HLTRH
96
QRTHT
101
GEKPY
106
QCNIC
111
GKCFS
116
CNSNL
121
HRHQR
126
THTGE
131
KPYKC
136
PECGE
141
IFAHS
146
SNLLR
151
HQRIH
156
TGERP
161
YKCPE
166
CGKSF
171
SRSSH
176
LVIHE
181
RTHER
186
ERLYP
191
FSECG
196
EAVSD
201
STPFL
206
TNHGA
211
HKAEK
216
KLFEC
221
LTCGK
226
SFRQG
231
MHLTR
236
HQRTH
241
TGEKP
246
YKCTL
251
CGENF
256
SHRSN
261
LIRHQ
266
RIHTG
271
EKPYT
276
CHECG
281
DSFSH
286
SSNRI
291
RHLRT
296
HTGER
301
PYKCS
306
ECGES
311
FSRSS
316
RLMSH
321
QRTHT
326
G
331
Mutation Information
DNA mutation:
None
Peptide Range:
266 ~ 290
Mut AA position:
630 (13 in Wild Type peptide)
Alignment
Wild Type:
"LIRHQRIHTGEKPYTCHECGDSFSH
||||||||||||.||||||||||||
Mutant:
LIRHQRIHTGEKSYTCHECGDSFSH"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) ZNF263
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay